Dietary fat and breast cancer risk in the Swedish women's lifestyle and health cohort.

Abstract:

:We investigated whether dietary intakes of total fat, monounsaturated fat (MUFA), polyunsaturated fat (PUFA) and saturated fat (SFA) were associated with breast cancer risk in a prospective cohort of 49 261 Swedish women (30-49 years at enrolment), which yielded 974 breast cancer cases by December 2005. Further, we evaluated if associations differed by oestrogen and/or progesterone receptor tumour status. Total fat, MUFA, PUFA or SFA were not associated with risk overall. However, women in the highest MUFA and PUFA quintile intake had a reduced breast cancer risk after age 50 years (hazard ratios: 95% confidence interval=0.45: 0.25-0.99 and 0.54: 0.35-0.85, respectively) compared to women in the lowest quintile. The associations did not differ by oestrogen or progesterone receptor status. Despite the negative findings, type of fat during premenopausal years may have later differential effects on risk.

journal_name

Br J Cancer

authors

Löf M,Sandin S,Lagiou P,Hilakivi-Clarke L,Trichopoulos D,Adami HO,Weiderpass E

doi

10.1038/sj.bjc.6604033

subject

Has Abstract

pub_date

2007-12-03 00:00:00

pages

1570-6

issue

11

eissn

0007-0920

issn

1532-1827

pii

6604033

journal_volume

97

pub_type

杂志文章
  • Cost-effectivenes of paclitaxel plus cisplatin in advanced non-small-cell lung cancer.

    abstract::The aim of this study was to assess the cost-effectiveness of combination chemotherapy with paclitaxel/cisplatin, compared with standard etoposide/cisplatin in patients with advanced non-small cell lung cancer (NSCLC). We obtained the primary survival and resource utilization data from a large three-arm randomized tri...

    journal_title:British journal of cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1038/sj.bjc.6690426

    authors: Earle CC,Evans WK

    更新日期:1999-05-01 00:00:00

  • Beta-adrenergic signalling in neoplastic lung type 2 cells: glucocorticoid-dependent and -independent defects.

    abstract::Tumorigenic mouse lung-derived type 2 cell lines have large reductions in both beta-adrenergic-stimulated cAMP production and ligand binding to beta-adrenergic receptors. These tumorigenic cells are also relatively insensitive to glucocorticoids. Because glucocorticoids regulate both beta-adrenergic receptor expressio...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1996.377

    authors: Droms KA

    更新日期:1996-08-01 00:00:00

  • Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma.

    abstract::Serum levels of the soluble epidermal growth factor receptor (sEGFR) and its ligands epidermal growth factor (EGF), transforming growth factor-alpha (TGF-alpha) and amphiregulin (AR) were measured in healthy donors and patients with non-small cell lung cancer (NSCLC) and head and neck carcinoma (HNC). In NSCLC, we fou...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6603770

    authors: Lemos-González Y,Rodríguez-Berrocal FJ,Cordero OJ,Gómez C,Páez de la Cadena M

    更新日期:2007-05-21 00:00:00

  • Prostaglandin-like material extracted from squamous carcinomas of the head and neck.

    abstract::Tumour-associated prostaglandin-like material, assessed by bioassay, has been examined in 37 patients with primary and metastatic squamous carcinomas of the head and neck, previously treated by radiotherapy and chemotherapy followed by radical surgery. High amounts of prostaglandin-like material were extracted from tu...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1980.31

    authors: Bennett A,Carter RL,Stamford IF,Tanner NS

    更新日期:1980-02-01 00:00:00

  • Do multiple oestrogen receptor assays give significant additional information for the management of breast cancer?

    abstract::In 101 breast cancer patients, measurement of oestrogen receptor status in multiple biopsies across a tumour reveals a highly significant difference in the proportion of patients remaining either disease-free (P less than 0.04) or alive (P less than 0.005), when those with uniformly receptor positive (++) primary tumo...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1989.129

    authors: Castagnetta L,Traina A,Di Carlo A,Carruba G,Lo Casto M,Mesiti M,Leake R

    更新日期:1989-04-01 00:00:00

  • Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III trial of Turkish Oncology Group.

    abstract::Our objective was to determine whether oral etoposide and cisplatin combination (EoP) is superior to paclitaxel in the treatment of advanced breast cancer (ABC) patients pretreated with anthracyclines. From December 1997 to August 2003, 201 patients were randomised, 100 to EoP and 101 to paclitaxel arms. Four patients...

    journal_title:British journal of cancer

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1038/sj.bjc.6602388

    authors: Icli F,Akbulut H,Uner A,Yalcin B,Baltali E,Altinbas M,Coşkun S,Komurcu S,Erkisi M,Demirkazik A,Senler FC,Sencan O,Büyükcelik A,Boruban C,Onur H,Zengin N,Sak SD

    更新日期:2005-02-28 00:00:00

  • Tamoxifen--the treatment of choice. Why look for alternatives?

    abstract::Tamoxifen is currently established as the endocrine treatment of choice in breast cancer. In advanced breast cancer, response rates of up to 60% in women with oestrogen receptor (ER)-positive tumours have been reported. In early breast cancer, tamoxifen can produce significant benefits, both statistically and clinical...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1998.753

    authors: Baum M

    更新日期:1998-09-01 00:00:00

  • Auditing the diagnosis of cancer in primary care: the experience in Scotland.

    abstract:INTRODUCTION:This paper reports on an ongoing primary care audit of cancer referrals undertaken in Scotland in 2006-2007 and 2007-2008. METHODS:General practitioners (GPs) in Scotland were asked to review all new cancer diagnoses within their practice during the preceding year. RESULTS:4181 patients were identified i...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6605397

    authors: Baughan P,O'Neill B,Fletcher E

    更新日期:2009-12-03 00:00:00

  • Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours.

    abstract:BACKGROUND:OCT3/4 (POU5F1) is an established diagnostic immunohistochemical marker for specific histological variants of human malignant germ cell tumours (GCTs), including the seminomatous types and the stem cell component of non-seminomas, known as embryonal carcinoma. OCT3/4 is crucial for the regulation of pluripot...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2011.270

    authors: Rijlaarsdam MA,van Herk HA,Gillis AJ,Stoop H,Jenster G,Martens J,van Leenders GJ,Dinjens W,Hoogland AM,Timmermans M,Looijenga LH

    更新日期:2011-09-06 00:00:00

  • Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer.

    abstract::People affected by cancer want information about their prognosis but clinicians have trouble estimating and talking about it. We sought to determine the nature and accuracy of medical oncologists' estimates of life expectancy in newly referred patients with incurable cancer. With reference to each patient, medical onc...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6602908

    authors: Stockler MR,Tattersall MH,Boyer MJ,Clarke SJ,Beale PJ,Simes RJ

    更新日期:2006-01-30 00:00:00

  • Linking the epigenetic 'language' of covalent histone modifications to cancer.

    abstract::Covalent modifications of histones, such as acetylation, methylation, and phosphorylation, and other epigenetic modulations of the chromatin, such as methylation of DNA and ATP-dependent chromatin reorganisation, can play a major part in the multistep process of carcinogenesis, with far-reaching implications for human...

    journal_title:British journal of cancer

    pub_type: 杂志文章,评审

    doi:10.1038/sj.bjc.6601575

    authors: Hake SB,Xiao A,Allis CD

    更新日期:2004-02-23 00:00:00

  • External multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours.

    abstract:BACKGROUND:The Obermair nomogram was recently developed to predict the risk of relapse in patients with borderline ovarian tumours (BOTs) based on five readily available clinical, biological, and pathological characteristics. We set out to externally validate and assess its robustness using a multi-institutional BOT da...

    journal_title:British journal of cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1038/bjc.2013.678

    authors: Bendifallah S,Uzan C,Fauvet R,Morice P,Darai E

    更新日期:2013-11-26 00:00:00

  • Preferential down-regulation of phospholipase C-beta in Ewing's sarcoma cells transfected with antisense EWS-Fli-1.

    abstract::EWS-Fli-1, a fusion gene found in Ewing's sarcoma and primitive neuro-ectodermal tumour (PNET), encodes a transcriptional activator and promotes cellular transformation. We have made stable Ewing's sarcoma cells expressing antisense EWS-Fli-1 transcripts by transfecting the antisense EWS-Fli-1 expression plasmid. Thes...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1054/bjoc.1998.0870

    authors: Dohjima T,Ohno T,Banno Y,Nozawa Y,Wen-yi Y,Shimizu K

    更新日期:2000-01-01 00:00:00

  • Ezrin promotes breast cancer progression by modulating AKT signals.

    abstract:BACKGROUND:Ezrin, which is known as a cytoskeleton linker protein, is closely linked with the metastatic progression of cancer and is frequently abnormally expressed in aggressive cancer types. However, the possible involvement of Ezrin in metastasis and angiogenesis in breast cancer remains unclear. METHODS:Immunohis...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/s41416-019-0383-z

    authors: Li N,Kong J,Lin Z,Yang Y,Jin T,Xu M,Sun J,Chen L

    更新日期:2019-04-01 00:00:00

  • Oestrogen and progesterone cytosolic receptors in clinically inflammatory tumours of the human breast.

    abstract::Oestrogen (RE) and progesterone (RP) cytosolic receptors have been studied in 59 clinically inflammatory tumours of the human breast. The results were compared to those obtained in a series of 496 operable tumours. A single saturating dose of oestradiol for RE and R 5020 for RP was used and the cut-off between negativ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1981.291

    authors: Delarue JC,May-Levin F,Mouriesse H,Contesso G,Sancho-Garnier H

    更新日期:1981-12-01 00:00:00

  • A phase II study of recombinant interferon-beta (r-hIFN-beta 1a) in combination with 5-fluorouracil (5-FU) in the treatment of patients with advanced colorectal carcinoma.

    abstract::The combination of 5-fluorouracil (5-FU) and interferon-alpha (IFN-alpha) has reported activity in the treatment of advanced colorectal carcinoma. Laboratory studies of IFN-beta suggest that this agent may offer theoretical advantages over IFN-alpha in combination with 5-FU. A total of 27 patients with advanced or rec...

    journal_title:British journal of cancer

    pub_type: 临床试验,杂志文章

    doi:10.1038/bjc.1997.69

    authors: Joffe JK,Perren TJ,Bradley C,Primrose J,Hallam S,Ward U,Illingworth JM,Selby PJ

    更新日期:1997-01-01 00:00:00

  • Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT.

    abstract::Chromosome 9p21 gene copy number in Ewing's sarcoma family of tumour (ESFT) cell lines and primary ESFT has been evaluated using Multiplex Ligation-dependent probe amplification, and the clinical significance of CDKN2A loss and p16/p14(ARF) expression investigated. Homozygous deletion of CDKN2A was identified in 4/9 (...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6603819

    authors: Brownhill SC,Taylor C,Burchill SA

    更新日期:2007-06-18 00:00:00

  • The 1987 Walter Hubert lecture. Regulation and deficiencies in DNA repair.

    abstract::A number of rare human inherited syndromes are associated with apparent defects in DNA repair and a greatly increased frequency of cancer. Cell lines derived from such individuals phenotypically resemble certain bacterial mutant strains that have increased sensitivity to radiation or chemical agents and well character...

    journal_title:British journal of cancer

    pub_type: 杂志文章,评审

    doi:10.1038/bjc.1987.163

    authors: Lindahl T

    更新日期:1987-08-01 00:00:00

  • Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma.

    abstract:BACKGROUND:Human papillomavirus (HPV) testing in oropharyngeal squamous cell carcinoma (OPSCC) is now advocated. Demonstration of transcriptionally active high-risk HPV (HR-HPV) in fresh tumour tissue is considered to be the analytical 'gold standard'. Clinical testing has focused on formalin-fixed paraffin-embedded (F...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2013.63

    authors: Schache AG,Liloglou T,Risk JM,Jones TM,Ma XJ,Wang H,Bui S,Luo Y,Sloan P,Shaw RJ,Robinson M

    更新日期:2013-04-02 00:00:00

  • Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma.

    abstract::The WWOX (WW-domain containing oxidoreductase) is a candidate tumour suppressor gene spanning the same chromosome region, 16q23, as the second most common fragile site (FS), FRA16D. Deletions detected by comparative genomic hybridisation (CGH) and loss of heterozygosity at microsatellite markers on chromosome 16q are ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6602023

    authors: Park SW,Ludes-Meyers J,Zimonjic DB,Durkin ME,Popescu NC,Aldaz CM

    更新日期:2004-08-16 00:00:00

  • Does thyroid-stimulating hormone influence the prognosis of patients with endometrial cancer? A multicentre trial.

    abstract:BACKGROUND:Thyroid function has been suggested to interfere with tumour biology and prognosis in different cancers. The present study was performed to investigate the impact of pre-therapeutic serum thyroid-stimulating hormone (TSH) levels on the prognosis of patients with endometrial cancer. METHODS:Pre-therapeutic s...

    journal_title:British journal of cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1038/bjc.2013.282

    authors: Seebacher V,Hofstetter G,Polterauer S,Reinthaller A,Grimm C,Schwameis R,Taucher S,Wagener A,Marth C,Concin N

    更新日期:2013-07-09 00:00:00

  • Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.

    abstract::Proton pump inhibitor (PPI) use leads to hypergastrinaemia, which has been associated with gastrointestinal neoplasia. We evaluated the association between PPI use and risk of gastric cancer using population-based health-care registers in North Jutland, Denmark, during 1990-2003. We compared incidence rates among new ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6605024

    authors: Poulsen AH,Christensen S,McLaughlin JK,Thomsen RW,Sørensen HT,Olsen JH,Friis S

    更新日期:2009-05-05 00:00:00

  • Hormone levels in older women: a study of post-menopausal breast cancer patients and healthy population controls.

    abstract::Hormone concentrations in blood and total 12 h urine values were compared between 40 post-menopausal women with breast cancer and 40 control women in a study which carefully controlled for the possible confounding effects of age, weight and pregnancy history by individually matching cases and controls on these factors...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1990.56

    authors: Bernstein L,Ross RK,Pike MC,Brown JB,Henderson BE

    更新日期:1990-02-01 00:00:00

  • Anti-tumour cytotoxin produced by human monocytes: studies on its mode of action.

    abstract::Human monocytes can be induced to synthesize a cytotoxin which affects certain tumour cell lines. The interaction of monocyte cytotoxin with a susceptible cell line (L929) has been studied to obtain clues to the mode of action of the cytotoxin. The cytotoxin acts directly on the cells rather than on the culture medium...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1983.205

    authors: Matthews N

    更新日期:1983-09-01 00:00:00

  • Anti-inflammation induced by counter-irritation or by treatment with non-steroidal agents inhibits the growth of a tumour of non-detected immunogenicity.

    abstract::Counter-irritation (CI) triggered by different non-specific irritant stimuli delayed the growth of a murine tumour of non-detected immunogenicity. The syngeneic LB tumour transplant by itself also induced CI and decreased the number of leukocytes migrating to a secondary s.c. irritant stimulus, e.g. sponge or carragee...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1989.349

    authors: Sordelli DO,Fontán PA,Meiss RP,Ruggiero RA,Bustuoabad OD

    更新日期:1989-11-01 00:00:00

  • Paediatric germ cell tumours and congenital abnormalities: a Children's Oncology Group study.

    abstract:METHODS:Maternally reported congenital abnormalities (CAs) were examined in a case-control study of 278 cases of paediatric germ cell tumours (GCTs) and 423 controls. RESULTS AND CONCLUSIONS:Germ cell tumours were significantly associated with cryptorchidism in males (OR=10.8, 95% CI: 2.1-55.1), but not with any other...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6605169

    authors: Johnson KJ,Ross JA,Poynter JN,Linabery AM,Robison LL,Shu XO

    更新日期:2009-08-04 00:00:00

  • Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays.

    abstract::Melanoma is one of the most aggressive types of cancer and resection of the tumour prior to dissemination of tumour cells is still the most effective treatment. Therefore, early diagnosis of melanocytic lesions is important and identification of novel (molecular) markers would be helpful to improve diagnosis. Moreover...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6602612

    authors: de Wit NJ,Rijntjes J,Diepstra JH,van Kuppevelt TH,Weidle UH,Ruiter DJ,van Muijen GN

    更新日期:2005-06-20 00:00:00

  • The efficacy of the anthracycline prodrug daunorubicin-GA3 in human ovarian cancer xenografts.

    abstract::The prodrug N-[4-(daunorubicin-N-carbonyl-oxymethyl)phenyl] O-beta-glucuronyl carbamate (DNR-GA3) was synthesized for specific activation by human beta-glucuronidase, released in necrotic areas of tumour lesions. In vitro, DNR-GA3 was 18 times less toxic than daunorubicin (DNR) and the prodrug was completely activated...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1998.729

    authors: Houba PH,Boven E,Erkelens CA,Leenders RG,Scheeren JW,Pinedo HM,Haisma HJ

    更新日期:1998-12-01 00:00:00

  • Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma.

    abstract::Id protein family consists of four members namely Id-1 to Id-4. Different from other basic helix-loop-helix transcription factors, they lack the DNA binding domain. Id proteins have been shown to be dysregulated in many different cancer types and their prognostic value has also been demonstrated. Recently, Id-1 has be...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6604035

    authors: Yuen HF,Chan YP,Chan KK,Chu YY,Wong ML,Law SY,Srivastava G,Wong YC,Wang X,Chan KW

    更新日期:2007-11-19 00:00:00

  • Assessing the benefit-risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer.

    abstract:BACKGROUND:Efficacy and safety are the two considerations when characterising the effects of a new therapy. We sought to apply an innovative method of assessing the benefit-risk balance using data from a completed randomised controlled trial that compared erlotinib vs placebo added to gemcitabine in patients with advan...

    journal_title:British journal of cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1038/bjc.2015.55

    authors: Péron J,Roy P,Ding K,Parulekar WR,Roche L,Buyse M

    更新日期:2015-03-17 00:00:00